Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 04 May, 2021

Schiehallion Fund

Issue of Equity

RNS Number : 5235X
Schiehallion Fund Limited (The)
04 May 2021

The Schiehallion Fund Limited (MNTN)

Legal Entity Identifier: 213800NQOLJA1JCWXQ56



Issue of Equity

The Board of The Schiehallion Fund Limited (the "Company") announces that, pursuant to its block listing facility, the Company has issued 250,000 ordinary shares of US$1 each (the "New Shares") on 4 May 2021 in order to meet ongoing market demand.  The New Shares, which rank pari passu with the Company's existing shares, were issued for cash at a price of 186.50 cents per ordinary share and at a premium to the last published net asset value.

As a result of this issue, the total number of ordinary shares in issue is 483,715,002.  The total number of C Class shares in issue is 700,000,000.  Therefore, the total number of voting rights in the Company is 1,183,715,002.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.



Baillie Gifford & Co Limited

4 May 2021

Regulated Information Classification:  Acquisition or disposal of the issuer's own shares


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t